OOIR: Observatory of International Research

Papers

(The TQCC of Heart Failure Clinics is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)

Article	Citations
Valvular Regurgitation in Adults with Congenital Heart Disease and Heart Failure	56
Unusual Forms of Pulmonary Hypertension	36
Tafamidis in the Treatment of ATTR-related Cardiomyopathy	29
Treatment of Advanced Heart Failure—Focus on Transplantation and Durable Mechanical Circulatory Support	26
Contents	26
Changing Landscape of Heart Failure Imaging	24
Forthcoming Issues	23
Viral Myocarditis and Dilated Cardiomyopathy as a Consequence—Changing Insights from Advanced Imaging	20
Diagnosis and Management of Cardiovascular Involvement in Friedreich Ataxia	20
Preload Reduction Therapies in Heart Failure	19
Understanding Myocardial Metabolism in the Context of Cardio-Oncology	19
When all Else Fails, Try This	19
Therapy-Related Clonal Hematopoiesis	19
Genetics of High-Altitude Pulmonary Edema	18
Mitral Regurgitation	18
Rare Cardiovascular Diseases: From Genetics to Personalized Medicine	18
Heart Failure in Adults with Congenital Heart Disease: The Time to Act is Now	17
Arrhythmias in Adult Congenital Heart Disease Heart Failure	16
Contributors	16
Contributors	15
Contributors	13
Copyright	13
Specific Therapy in Transthyretin Amyloid Cardiomyopathy	13
Contributors	12
Emerging Roles for Artificial Intelligence in Heart Failure Imaging	12

Medical Therapy and Monitoring in Adult Congenital Heart Disease Heart Failure	12
Myocardial Dysfunction in Patients with Cancer	12
Arrythmia-Mediated Valvular Heart Disease	11
Special Considerations for Mechanical Circulatory Support or Device Therapy in Adult Congenital Heart Disease Heart Failure	11
What Is New in Risk Assessment in Nuclear Cardiology?	11
Guide to Temporary Mechanical Support in Cardiogenic Shock	10
The Role of Echocardiography for the Clinical Diagnosis, Risk Stratification, and Management of Cardiac Amyloidosis	10
Heart Failure Clinics	10
Advanced Heart Failure in a Special Population	10
Redefining Left Ventricular Systolic Dysfunction in Hypertrophic Cardiomyopathy	10
Coronary Angiography in the Evaluation of Systolic Heart Failure	10
Evaluation and Management of Cardiac Sarcoidosis with Advanced Imaging	9
Cardiac Contractility Modulation	9
SGLT2 Inhibitors in Heart Failure	9
Cardiac Amyloidosis	9
Application of 3D Printing Technology in Heart Failure	9
Interventional Management of Atrial Fibrillation in the Chronic Heart Failure Population	9
Obtaining a Coronary Artery Calcium Score with Myocardial Perfusion Imaging	9
Noncoding RNAs in Pulmonary Arterial Hypertension	9
Contributors	8
The Role of Multimodality Imaging in the Evaluation of Heart Failure and Surgical Transplant Planning of Patients with Adult Congenital Heart Disease	8
Contents	8
Copyright	8
Pulmonary Arterial Hypertension in Connective Tissue Diseases Beyond Systemic Sclerosis	8
Exercise Training and Rehabilitation in Cardiac Amyloidosis (ERICA) Study	7
Contents	7
Echocardiography in Advanced Heart Failure for Diagnosis, Management, and Prognosis	7
Disease-modifier Drugs in Patients with Advanced Heart Failure	7
Preface	7
The Direct and Indirect Effects of COVID-19 on Acute Coronary Syndromes	7
Inotropes in Patients with Advanced Heart Failure	6
Advanced Heart Failure in Special Population	6
Aortic Valvular Stenosis and Heart Failure	6
Advanced Heart Failure: From Pathophysiology to Clinical Management	6
Glucose-Lowering and Metabolic Effects of SGLT2 Inhibitors	6
Radionuclide Tracers for Myocardial Perfusion Imaging and Blood Flow Quantification	6
SGLT2 Inhibitors in Type 2 Diabetes Mellitus	6
Copyright	6
Contents	6
Exercise Testing in Pulmonary Hypertension and Heart Failure	5
Adults with Congenital Heart Disease and Transplant	5
Evaluation and Management of Arrhythmias in Ischemic Cardiomyopathy	5
Contents	5
Remote Monitoring Devices and Heart Failure	5
Vision Statement and Call to Action for Adult Congenital Heart Disease Heart Failure	5
Clinical Practice Guidelines in Cardio-Oncology	4
SGLT2 Inhibitors and Peripheral Vascular Events	4
The Risk of Sudden Unexpected Cardiac Death in Children	4
Clinical Use of Biomarkers in Cardiac Amyloidosis	4
Contributors	4

The Role of Medical Therapy in Hypertrophic Cardiomyopathy	4
Novel Non-pharmacological Approaches to Heart Failure	4
Pathophysiology of Cardiac Amyloidosis	4